Several studies also conclude limited to no increases in clinical severity with COVID-19 in people living with HIV, especially with normal CD4+ T lymphocyte counts due to effectively administered antiretroviral therapy [59,60,61,62]. The gene discussed is CD4; the disease is COVID-19.